SCAI news: REDUCE-IT, fasting before catheterization, telehealth and more
Healio and Cardiology Today have curated a list of the top news from the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions.
Readers were interested in the practice of fasting before cardiac catheterization, an analysis of the REDUCE-IT trial, telehealth in Latin America and more.
New study questions fasting before cardiac catheterization
Patients undergoing cardiac catheterization are generally instructed to follow nothing by mouth, or NPO, before the procedure. A single-center study reported at the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions showed no significant difference in adverse events with standard fasting compared with unrestricted oral intake. Read more
No difference by hospital volume in events after TAVR for bicuspid aortic valves
Low- and high-volume hospitals that performed transcatheter aortic valve replacement for bicuspid aortic valves had similar rates of in-hospital and 30-day outcomes, according to data presented at the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions. Read more
Icosapent ethyl reduces revascularization events: REDUCE-IT REVASC
A prespecified analysis of the REDUCE-IT trial highlighted a reduction in first and total revascularization events with icosapent ethyl in patients with elevated triglycerides at high CV risk despite statin therapy. Read more
ISCHEMIA: Intermediate left main disease confers poor prognosis; invasive strategy improves angina symptoms
In a new analysis from the ISCHEMIA trial of patients with stable ischemic heart disease, those with intermediate left main disease had worse prognosis than those with little or no left main stenosis, but an invasive strategy improved their angina-related quality of life. Read more
Cell therapy improves coronary flow reserve in coronary microvascular dysfunction
CD34+ cell therapy in patients with coronary microvascular dysfunction improved coronary flow reserve in addition to angina class and symptoms at 6 months, according to data from the ESCaPE-CMD trial presented at the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions. Read more
SCAI document identifies patients appropriate for PCI in ASCs
CMS in January commenced reimbursement for PCI procedures performed in ASCs. However, existing PCI guidelines assume the procedure occurs in a hospital, so the Society for Cardiovascular Angiography and Interventions released a position statement identifying appropriate patients to undergo PCI in an ASC and advising on requirements for starting a PCI program in such a center. Read more
Success, event rates similar after PCI for in-stent, de novo CTO
PCI for in-stent chronic total occlusion had similar success rates and in-hospital complications compared with PCI for de novo CTO, according to data presented at the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions. Read more
Telehealth strategy improves STEMI care in Latin America
A telehealth strategy implemented in four countries in Latin America was associated with improvements in optimal treatment of STEMI and time to diagnosis, according to the LATIN study presented at the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions. Read more
Ticagrelor monotherapy reduces bleeding risk after PCI regardless of DES platform
Among patients who underwent PCI with a drug-eluting stent and were prescribed dual antiplatelet therapy for 3 months, subsequent ticagrelor monotherapy reduced bleeding risk compared with continued DAPT regardless of DES type, according to results from the TWILIGHT-SYNERGY study. Read more